Follow
Kasper Drimer Berg
Kasper Drimer Berg
MD, PhD, Copenhagen Prostate Cancer Center, Københavns Universitet
Verified email at regionh.dk
Title
Cited by
Cited by
Year
Active surveillance for clinically localized prostate cancer––A systematic review
FB Thomsen, K Brasso, LH Klotz, MA Røder, KD Berg, P Iversen
Journal of surgical oncology 109 (8), 830-835, 2014
2482014
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ...
The Lancet Oncology 22 (11), 1507-1517, 2021
2442021
ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer
KD Berg, B Vainer, FB Thomsen, MA Røder, TA Gerds, BG Toft, K Brasso, ...
European urology 66 (5), 851-860, 2014
1082014
Does cytoreductive prostatectomy really have an impact on prognosis in prostate cancer patients with low-volume bone metastasis? Results from a prospective case-control study
T Steuber, KD Berg, MA Røder, K Brasso, P Iversen, H Huland, A Tiebel, ...
European urology focus 3 (6), 646-649, 2017
1002017
TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomy
KD Berg, D Soldini, M Jung, D Dietrich, C Stephan, K Jung, M Dietel, ...
Virchows Archiv 468, 345-355, 2016
452016
Serum testosterone level as a predictor of biochemical failure after radical prostatectomy for localized prostate cancer
MA Røder, IJ Christensen, KD Berg, L Gruschy, K Brasso, P Iversen
BJU international 109 (4), 520-524, 2012
412012
Improved survival for patients with de novo metastatic prostate cancer in the last 20 years
KD Berg, FB Thomsen, MK Mikkelsen, IJ Ingimarsdóttir, RB Hansen, ...
European Journal of Cancer 72, 20-27, 2017
402017
The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy
S Kurbegovic, KD Berg, FB Thomsen, L Gruschy, P Iversen, K Brasso, ...
Scandinavian journal of urology 51 (6), 450-456, 2017
332017
Prostate needle biopsies: interobserver variation and clinical consequences of histopathological re‐evaluation
KD Berg, BG Toft, MA Røder, K Brasso, B Vainer, P Iversen
Apmis 119 (4‐5), 239-246, 2011
332011
Robot-assisted pyeloplasty and pyelolithotomy in patients with ureteropelvic junction stenosis
PH Jensen, KD Berg, NH Azawi
Scandinavian Journal of Urology 51 (4), 323-328, 2017
282017
The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading–a matched‐pair analysis
KD Berg, FB Thomsen, C Nerstrøm, MA Røder, P Iversen, BG Toft, ...
BJU international 117 (6), 883-889, 2016
252016
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study
FB Thomsen, K Brasso, KD Berg, TA Gerds, JE Johansson, A Angelsen, ...
Annals of Oncology 27 (3), 460-466, 2016
242016
Systematic review: does endocrine therapy prolong survival in patients with prostate cancer?
JT Helgstrand, KD Berg, S Lippert, K Brasso, MA Røder
Scandinavian journal of urology 50 (3), 135-143, 2016
232016
Anastomotic complications after robot-assisted laparoscopic and open radical prostatectomy
A Jacobsen, KD Berg, P Iversen, K Brasso, MA Røder
Scandinavian journal of urology 50 (4), 274-279, 2016
222016
The prognostic and predictive value of TMPRSS2-ERG gene fusion and ERG protein expression in prostate cancer biopsies
KD Berg
Dan Med J 63 (12), B5319, 2016
212016
First danish single‐institution experience with radical prostatectomy: biochemical outcome in 1200 consecutive patients
MA Røder, KD Berg, L Gruschy, K Brasso, P Iversen
Prostate Cancer 2011 (1), 236357, 2011
192011
Active surveillance for localized prostate cancer: an analysis of patient contacts and utilization of healthcare resources
FB Thomsen, KD Berg, MA Røder, P Iversen, K Brasso
Scandinavian Journal of Urology 49 (1), 43-50, 2015
162015
Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy
MK Mikkelsen, FB Thomsen, KD Berg, M Jarden, SB Larsen, RB Hansen, ...
Scandinavian Journal of Urology 51 (6), 464-469, 2017
152017
Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early results
S Lippert, KD Berg, G Høyer-Hansen, IK Lund, P Iversen, IJ Christensen, ...
Biomarkers in Medicine 10 (2), 209-216, 2016
152016
Primary Gleason pattern in biopsy Gleason score 7 is predictive of adverse histopathological features and biochemical failure following radical prostatectomy
KD Berg, MA Røder, K Brasso, B Vainer, P Iversen
Scand J Urol. Suppl. 47, 1-67: A53, 2013
152013
The system can't perform the operation now. Try again later.
Articles 1–20